Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Net Income towards Common Stockholders (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Net Income towards Common Stockholders for 3 consecutive years, with $12.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders rose 352.76% year-over-year to $12.8 million, compared with a TTM value of $45.5 million through Sep 2025, up 20.09%, and an annual FY2024 reading of $46.7 million, up 15395.48% over the prior year.
  • Net Income towards Common Stockholders was $12.8 million for Q3 2025 at SBC Medical Group Holdings, up from $2.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $48.7 million in Q3 2023 and bottomed at -$292546.0 in Q1 2024.
  • Average Net Income towards Common Stockholders over 3 years is $12.0 million, with a median of $8.7 million recorded in 2024.
  • Peak annual rise in Net Income towards Common Stockholders hit 7824.94% in 2024, while the deepest fall reached 349.97% in 2024.
  • Year by year, Net Income towards Common Stockholders stood at $19.7 million in 2023, then tumbled by 55.88% to $8.7 million in 2024, then skyrocketed by 47.46% to $12.8 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for SBC at $12.8 million in Q3 2025, $2.4 million in Q2 2025, and $21.5 million in Q1 2025.